Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 800 results for "novartis"

European Ad Comm backs Novartis' Entresto for heart failure

European Ad Comm backs Novartis' Entresto for heart failure

European Ad Comm backs Novartis' Entresto for heart failure The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopts a positive opinion recommending approval of Novartis' (NVS +1.2% ) Entresto ..., 3 days ago
XOMA Forms Pact With Novartis Contract Pharma, 6 days ago
Pharmaceutical Technology

GSK Pharma completes acquisition of Novartis Healthcare's vaccines business

GlaxoSmithKline Pharmaceuticals has completed the acquisition of Novartis Healthcare's vaccines business, while selling its marketed oncology portfolio to Novartis India. The deal follows a global transaction between their parent companies ...
 Pharmaceutical Technology1 week ago
Business Today India

Torrent wins patent battle against Novartis' drug Gilenya in US

Global pharmaceutical major Novartis AG and Mitsubishi Pharma Corporation have lost a patent fight with Ahmedabad-based Torrent Pharmaceuticals in the US over Novartis' block buster multiple sclerosis drug Gilenya. The US Patent and Trademark ...
 Business Today India1 week ago Novartis is the latest Big Pharma player to extend olive branch in Third World patent rights row  Intellectual Asset Management1 week ago
Siasat Daily

Senior Expert DMA

Novartis Healthcare Pvt. Ltd. 2 6 yrs Hyderabad / Secunderabad Job Description: Provide analytics support to Novartis internal customers (CPOs & Regional marketing and sales teams) on various low-medium complexity analytical reports.
 Siasat Daily1 week ago

Novartis Pharma, Sanofi R&D, GSK R&D, Amgen, MHRA, Allergan to present at Pre-Filled Syringes 2016

, London): Pre-Filled Syringes 2016 returns to London next January. With a selected 100+ representatives from the world's leading Pharmaceutical and Biotechnology businesses, delegates will learn the A-Z journey of PFS. (PRWeb September 29, 2015) ...
 PRWeb1 week ago

Phenotypic Assays - A New Age of Modelling Disease: 15 Progressive Insights from Novartis, Astra Zeneca, GSK, Pfizer and Johnson & Johnson

Advances in Cell Based Assays 2015 "I am looking forward to the presentations that discuss the implementation of high content imaging in combination with the use of 3D models" - Netherlands Cancer Institute London, England (PRWEB UK) 28 ...
 PRWeb1 week ago
Washington Post

Novartis CEO talks about drug costs, paying doctors and 'doing the right thing'

As stories of jacked-up drug costs make news, and discussions of health-care reform pepperthe campaign trail, Novartis CEO Joseph Jimenez sat down with The Washington Post to talk abouthow he viewshis responsibility as leader of one of the world's ...
 Washington Post2 weeks ago
Jutia Group

Market Update (NASDAQ:AMGN): Novartis biosimilar copycat takes aim at Amgen's drug Enbrel

[Reuters] The U.S. Food and Drug Administration has accepted Novartis unit Sandoz's regulatory submission for approval of a biosimilar copy of Amgen's blockbuster Enbrel drug, the Swiss drugmaker said on Friday. Biosimilars aim to copy biologic ...
 Jutia Group6 days ago FDA accepts Sandoz submission for Amgen biosimilar  Pharmafile1 week ago Novartis biosimilar copycat takes aim at Amgen's drug Enbrel  4 Traders1 week ago Novartis copycat product takes aim at Amgen's Enbrel  4 Traders1 week ago
Pharma Letter

Long-term efficacy profile of Novartis' Gilenya reinforced by study

New analysis from Phase III trials has reinforced the long-term efficacy profile of Gilenya (fingolimod) from Swiss pharma giant Novartis (VX: NOVN). The analysis looked at the proportion of Gilenya patients with relapsing multiple sclerosis ...
 Pharma Letter1 day ago Novartis releases long-term efficacy results for Gilenya in MS  European Pharmaceutical Review1 day ago Novartis looks to new measure of Gilenya outcomes  Pharmafile1 day ago

Smart Contact Lens Set for Human Trials

More than a year after its release, Google and Novartis are reportedly ready to start testing their smart lens designed to correct vision for people with presbyopia in human trials in 2016. Novartis CEO, Joe Jimenez told Reuters the company is ... day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - novartis
Get updated on latest news & your favorite topics right in your inbox!
More     Less